Peptides are generally destroyed in the gastrointestinal tract and absorbed poorly, which historically restricted GLP-1 analogues to injectable formats
Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
Medical advice is to stop taking tirzepatide before pregnancy begins and to avoid its use during pregnancy
Leberschutz Die Leberheilpflanzen Kurkuma und Mariendistel knnen den Glutathionspiegel in der Leber erhhen
With intensive behavioral therapy, you may even reach a higher reduction
While the total amount of weight you can lose on semaglutide is pretty significant studies show people can lose an average of 15-18.7% of their weight, depending on their dose, after a little more than a year it doesnt all happen at once